線維芽細胞成長因子（FGF）のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Fibroblast Growth Factors (FGF) Market Insights, Forecast to 2028

• レポートコード：QY2207C3832 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の線維芽細胞成長因子（FGF）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に線維芽細胞成長因子（FGF）の世界市場のxxx％を占める「FGF1」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「循環器疾患」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の線維芽細胞成長因子（FGF）の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの線維芽細胞成長因子（FGF）市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの線維芽細胞成長因子（FGF）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 線維芽細胞成長因子（FGF）のグローバル主要メーカーには、ProSpec、Thermo Fisher Scientific、Peprotech、Essex Bio-Technology、Corning、Lonza、Shanghai Tenry Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 線維芽細胞成長因子（FGF）市場は、種類と用途によって区分されます。世界の線維芽細胞成長因子（FGF）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 FGF1、FGF4、FGF7、FGF8、FGF9、FGF11、FGF19 【用途別セグメント】 循環器疾患、皮膚病、がん、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 線維芽細胞成長因子（FGF）製品概要 - 種類別市場（FGF1、FGF4、FGF7、FGF8、FGF9、FGF11、FGF19） - 用途別市場（循環器疾患、皮膚病、がん、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の線維芽細胞成長因子（FGF）販売量予測2017-2028 - 世界の線維芽細胞成長因子（FGF）売上予測2017-2028 - 線維芽細胞成長因子（FGF）の地域別販売量 - 線維芽細胞成長因子（FGF）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別線維芽細胞成長因子（FGF）販売量 - 主要メーカー別線維芽細胞成長因子（FGF）売上 - 主要メーカー別線維芽細胞成長因子（FGF）価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（FGF1、FGF4、FGF7、FGF8、FGF9、FGF11、FGF19） - 線維芽細胞成長因子（FGF）の種類別販売量 - 線維芽細胞成長因子（FGF）の種類別売上 - 線維芽細胞成長因子（FGF）の種類別価格 ・用途別市場規模（循環器疾患、皮膚病、がん、その他） - 線維芽細胞成長因子（FGF）の用途別販売量 - 線維芽細胞成長因子（FGF）の用途別売上 - 線維芽細胞成長因子（FGF）の用途別価格 ・北米市場 - 北米の線維芽細胞成長因子（FGF）市場規模（種類別、用途別） - 主要国別の線維芽細胞成長因子（FGF）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの線維芽細胞成長因子（FGF）市場規模（種類別、用途別） - 主要国別の線維芽細胞成長因子（FGF）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の線維芽細胞成長因子（FGF）市場規模（種類別、用途別） - 主要国別の線維芽細胞成長因子（FGF）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の線維芽細胞成長因子（FGF）市場規模（種類別、用途別） - 主要国別の線維芽細胞成長因子（FGF）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの線維芽細胞成長因子（FGF）市場規模（種類別、用途別） - 主要国別の線維芽細胞成長因子（FGF）市場規模（トルコ、サウジアラビア） ・企業情報 ProSpec、Thermo Fisher Scientific、Peprotech、Essex Bio-Technology、Corning、Lonza、Shanghai Tenry Pharmaceutical ・産業チェーン及び販売チャネル分析 - 線維芽細胞成長因子（FGF）の産業チェーン分析 - 線維芽細胞成長因子（FGF）の原材料 - 線維芽細胞成長因子（FGF）の生産プロセス - 線維芽細胞成長因子（FGF）の販売及びマーケティング - 線維芽細胞成長因子（FGF）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 線維芽細胞成長因子（FGF）の産業動向 - 線維芽細胞成長因子（FGF）のマーケットドライバー - 線維芽細胞成長因子（FGF）の課題 - 線維芽細胞成長因子（FGF）の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Fibroblast Growth Factors (FGF) Market
Due to the COVID-19 pandemic, the global Fibroblast Growth Factors (FGF) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, FGF1 accounting for % of the Fibroblast Growth Factors (FGF) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cardiovascular Diseases segment is altered to an % CAGR throughout this forecast period.
China Fibroblast Growth Factors (FGF) market size is valued at US$ million in 2021, while the US and Europe Fibroblast Growth Factors (FGF) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fibroblast Growth Factors (FGF) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Fibroblast Growth Factors (FGF) include ProSpec, Thermo Fisher Scientific, Peprotech, Essex Bio-Technology, Corning, Lonza and Shanghai Tenry Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Fibroblast Growth Factors (FGF) Scope and Segment
Fibroblast Growth Factors (FGF) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Fibroblast Growth Factors (FGF) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
FGF1
FGF4
FGF7
FGF8
FGF9
FGF11
FGF19
Segment by Application
Cardiovascular Diseases
Skin Disease
Cancer
Other
By Company
ProSpec
Thermo Fisher Scientific
Peprotech
Essex Bio-Technology
Corning
Lonza
Shanghai Tenry Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Fibroblast Growth Factors (FGF) Product Introduction
1.2 Market by Type
1.2.1 Global Fibroblast Growth Factors (FGF) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 FGF1
1.2.3 FGF4
1.2.4 FGF7
1.2.5 FGF8
1.2.6 FGF9
1.2.7 FGF11
1.2.8 FGF19
1.3 Market by Application
1.3.1 Global Fibroblast Growth Factors (FGF) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cardiovascular Diseases
1.3.3 Skin Disease
1.3.4 Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Fibroblast Growth Factors (FGF) Sales Estimates and Forecasts 2017-2028
2.2 Global Fibroblast Growth Factors (FGF) Revenue Estimates and Forecasts 2017-2028
2.3 Global Fibroblast Growth Factors (FGF) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Fibroblast Growth Factors (FGF) Sales by Region
2.4.1 Global Fibroblast Growth Factors (FGF) Sales by Region (2017-2022)
2.4.2 Global Sales Fibroblast Growth Factors (FGF) by Region (2023-2028)
2.5 Global Fibroblast Growth Factors (FGF) Revenue by Region
2.5.1 Global Fibroblast Growth Factors (FGF) Revenue by Region (2017-2022)
2.5.2 Global Fibroblast Growth Factors (FGF) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Fibroblast Growth Factors (FGF) Sales by Manufacturers
3.1.1 Global Top Fibroblast Growth Factors (FGF) Manufacturers by Sales (2017-2022)
3.1.2 Global Fibroblast Growth Factors (FGF) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fibroblast Growth Factors (FGF) in 2021
3.2 Global Fibroblast Growth Factors (FGF) Revenue by Manufacturers
3.2.1 Global Fibroblast Growth Factors (FGF) Revenue by Manufacturers (2017-2022)
3.2.2 Global Fibroblast Growth Factors (FGF) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Fibroblast Growth Factors (FGF) Revenue in 2021
3.3 Global Fibroblast Growth Factors (FGF) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Fibroblast Growth Factors (FGF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Fibroblast Growth Factors (FGF) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Fibroblast Growth Factors (FGF) Sales by Type
4.1.1 Global Fibroblast Growth Factors (FGF) Historical Sales by Type (2017-2022)
4.1.2 Global Fibroblast Growth Factors (FGF) Forecasted Sales by Type (2023-2028)
4.1.3 Global Fibroblast Growth Factors (FGF) Sales Market Share by Type (2017-2028)
4.2 Global Fibroblast Growth Factors (FGF) Revenue by Type
4.2.1 Global Fibroblast Growth Factors (FGF) Historical Revenue by Type (2017-2022)
4.2.2 Global Fibroblast Growth Factors (FGF) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Fibroblast Growth Factors (FGF) Revenue Market Share by Type (2017-2028)
4.3 Global Fibroblast Growth Factors (FGF) Price by Type
4.3.1 Global Fibroblast Growth Factors (FGF) Price by Type (2017-2022)
4.3.2 Global Fibroblast Growth Factors (FGF) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Fibroblast Growth Factors (FGF) Sales by Application
5.1.1 Global Fibroblast Growth Factors (FGF) Historical Sales by Application (2017-2022)
5.1.2 Global Fibroblast Growth Factors (FGF) Forecasted Sales by Application (2023-2028)
5.1.3 Global Fibroblast Growth Factors (FGF) Sales Market Share by Application (2017-2028)
5.2 Global Fibroblast Growth Factors (FGF) Revenue by Application
5.2.1 Global Fibroblast Growth Factors (FGF) Historical Revenue by Application (2017-2022)
5.2.2 Global Fibroblast Growth Factors (FGF) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Fibroblast Growth Factors (FGF) Revenue Market Share by Application (2017-2028)
5.3 Global Fibroblast Growth Factors (FGF) Price by Application
5.3.1 Global Fibroblast Growth Factors (FGF) Price by Application (2017-2022)
5.3.2 Global Fibroblast Growth Factors (FGF) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Fibroblast Growth Factors (FGF) Market Size by Type
6.1.1 North America Fibroblast Growth Factors (FGF) Sales by Type (2017-2028)
6.1.2 North America Fibroblast Growth Factors (FGF) Revenue by Type (2017-2028)
6.2 North America Fibroblast Growth Factors (FGF) Market Size by Application
6.2.1 North America Fibroblast Growth Factors (FGF) Sales by Application (2017-2028)
6.2.2 North America Fibroblast Growth Factors (FGF) Revenue by Application (2017-2028)
6.3 North America Fibroblast Growth Factors (FGF) Market Size by Country
6.3.1 North America Fibroblast Growth Factors (FGF) Sales by Country (2017-2028)
6.3.2 North America Fibroblast Growth Factors (FGF) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Fibroblast Growth Factors (FGF) Market Size by Type
7.1.1 Europe Fibroblast Growth Factors (FGF) Sales by Type (2017-2028)
7.1.2 Europe Fibroblast Growth Factors (FGF) Revenue by Type (2017-2028)
7.2 Europe Fibroblast Growth Factors (FGF) Market Size by Application
7.2.1 Europe Fibroblast Growth Factors (FGF) Sales by Application (2017-2028)
7.2.2 Europe Fibroblast Growth Factors (FGF) Revenue by Application (2017-2028)
7.3 Europe Fibroblast Growth Factors (FGF) Market Size by Country
7.3.1 Europe Fibroblast Growth Factors (FGF) Sales by Country (2017-2028)
7.3.2 Europe Fibroblast Growth Factors (FGF) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Fibroblast Growth Factors (FGF) Market Size by Type
8.1.1 Asia Pacific Fibroblast Growth Factors (FGF) Sales by Type (2017-2028)
8.1.2 Asia Pacific Fibroblast Growth Factors (FGF) Revenue by Type (2017-2028)
8.2 Asia Pacific Fibroblast Growth Factors (FGF) Market Size by Application
8.2.1 Asia Pacific Fibroblast Growth Factors (FGF) Sales by Application (2017-2028)
8.2.2 Asia Pacific Fibroblast Growth Factors (FGF) Revenue by Application (2017-2028)
8.3 Asia Pacific Fibroblast Growth Factors (FGF) Market Size by Region
8.3.1 Asia Pacific Fibroblast Growth Factors (FGF) Sales by Region (2017-2028)
8.3.2 Asia Pacific Fibroblast Growth Factors (FGF) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Fibroblast Growth Factors (FGF) Market Size by Type
9.1.1 Latin America Fibroblast Growth Factors (FGF) Sales by Type (2017-2028)
9.1.2 Latin America Fibroblast Growth Factors (FGF) Revenue by Type (2017-2028)
9.2 Latin America Fibroblast Growth Factors (FGF) Market Size by Application
9.2.1 Latin America Fibroblast Growth Factors (FGF) Sales by Application (2017-2028)
9.2.2 Latin America Fibroblast Growth Factors (FGF) Revenue by Application (2017-2028)
9.3 Latin America Fibroblast Growth Factors (FGF) Market Size by Country
9.3.1 Latin America Fibroblast Growth Factors (FGF) Sales by Country (2017-2028)
9.3.2 Latin America Fibroblast Growth Factors (FGF) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Fibroblast Growth Factors (FGF) Market Size by Type
10.1.1 Middle East and Africa Fibroblast Growth Factors (FGF) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Fibroblast Growth Factors (FGF) Revenue by Type (2017-2028)
10.2 Middle East and Africa Fibroblast Growth Factors (FGF) Market Size by Application
10.2.1 Middle East and Africa Fibroblast Growth Factors (FGF) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Fibroblast Growth Factors (FGF) Revenue by Application (2017-2028)
10.3 Middle East and Africa Fibroblast Growth Factors (FGF) Market Size by Country
10.3.1 Middle East and Africa Fibroblast Growth Factors (FGF) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Fibroblast Growth Factors (FGF) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ProSpec
11.1.1 ProSpec Corporation Information
11.1.2 ProSpec Overview
11.1.3 ProSpec Fibroblast Growth Factors (FGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ProSpec Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ProSpec Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Overview
11.2.3 Thermo Fisher Scientific Fibroblast Growth Factors (FGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Thermo Fisher Scientific Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Peprotech
11.3.1 Peprotech Corporation Information
11.3.2 Peprotech Overview
11.3.3 Peprotech Fibroblast Growth Factors (FGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Peprotech Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Peprotech Recent Developments
11.4 Essex Bio-Technology
11.4.1 Essex Bio-Technology Corporation Information
11.4.2 Essex Bio-Technology Overview
11.4.3 Essex Bio-Technology Fibroblast Growth Factors (FGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Essex Bio-Technology Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Essex Bio-Technology Recent Developments
11.5 Corning
11.5.1 Corning Corporation Information
11.5.2 Corning Overview
11.5.3 Corning Fibroblast Growth Factors (FGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Corning Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Corning Recent Developments
11.6 Lonza
11.6.1 Lonza Corporation Information
11.6.2 Lonza Overview
11.6.3 Lonza Fibroblast Growth Factors (FGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lonza Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lonza Recent Developments
11.7 Shanghai Tenry Pharmaceutical
11.7.1 Shanghai Tenry Pharmaceutical Corporation Information
11.7.2 Shanghai Tenry Pharmaceutical Overview
11.7.3 Shanghai Tenry Pharmaceutical Fibroblast Growth Factors (FGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shanghai Tenry Pharmaceutical Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai Tenry Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Fibroblast Growth Factors (FGF) Industry Chain Analysis
12.2 Fibroblast Growth Factors (FGF) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fibroblast Growth Factors (FGF) Production Mode & Process
12.4 Fibroblast Growth Factors (FGF) Sales and Marketing
12.4.1 Fibroblast Growth Factors (FGF) Sales Channels
12.4.2 Fibroblast Growth Factors (FGF) Distributors
12.5 Fibroblast Growth Factors (FGF) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Fibroblast Growth Factors (FGF) Industry Trends
13.2 Fibroblast Growth Factors (FGF) Market Drivers
13.3 Fibroblast Growth Factors (FGF) Market Challenges
13.4 Fibroblast Growth Factors (FGF) Market Restraints
14 Key Findings in The Global Fibroblast Growth Factors (FGF) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Fibroblast Growth Factors (FGF) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of FGF1
Table 3. Major Manufacturers of FGF4
Table 4. Major Manufacturers of FGF7
Table 5. Major Manufacturers of FGF8
Table 6. Major Manufacturers of FGF9
Table 7. Major Manufacturers of FGF11
Table 8. Major Manufacturers of FGF19
Table 9. Global Fibroblast Growth Factors (FGF) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Fibroblast Growth Factors (FGF) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Fibroblast Growth Factors (FGF) Sales by Region (2017-2022) & (K Units)
Table 12. Global Fibroblast Growth Factors (FGF) Sales Market Share by Region (2017-2022)
Table 13. Global Fibroblast Growth Factors (FGF) Sales by Region (2023-2028) & (K Units)
Table 14. Global Fibroblast Growth Factors (FGF) Sales Market Share by Region (2023-2028)
Table 15. Global Fibroblast Growth Factors (FGF) Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Fibroblast Growth Factors (FGF) Revenue Market Share by Region (2017-2022)
Table 17. Global Fibroblast Growth Factors (FGF) Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Fibroblast Growth Factors (FGF) Revenue Market Share by Region (2023-2028)
Table 19. Global Fibroblast Growth Factors (FGF) Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Fibroblast Growth Factors (FGF) Sales Share by Manufacturers (2017-2022)
Table 21. Global Fibroblast Growth Factors (FGF) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Fibroblast Growth Factors (FGF) Revenue Share by Manufacturers (2017-2022)
Table 23. Fibroblast Growth Factors (FGF) Price by Manufacturers (2017-2022) &(US$/Unit)
Table 24. Global Fibroblast Growth Factors (FGF) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Fibroblast Growth Factors (FGF) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibroblast Growth Factors (FGF) as of 2021)
Table 26. Fibroblast Growth Factors (FGF) Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Fibroblast Growth Factors (FGF) Product Offered
Table 28. Date of Manufacturers Enter into Fibroblast Growth Factors (FGF) Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Fibroblast Growth Factors (FGF) Sales by Type (2017-2022) & (K Units)
Table 31. Global Fibroblast Growth Factors (FGF) Sales by Type (2023-2028) & (K Units)
Table 32. Global Fibroblast Growth Factors (FGF) Sales Share by Type (2017-2022)
Table 33. Global Fibroblast Growth Factors (FGF) Sales Share by Type (2023-2028)
Table 34. Global Fibroblast Growth Factors (FGF) Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Fibroblast Growth Factors (FGF) Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Fibroblast Growth Factors (FGF) Revenue Share by Type (2017-2022)
Table 37. Global Fibroblast Growth Factors (FGF) Revenue Share by Type (2023-2028)
Table 38. Fibroblast Growth Factors (FGF) Price by Type (2017-2022) & (US$/Unit)
Table 39. Global Fibroblast Growth Factors (FGF) Price Forecast by Type (2023-2028) & (US$/Unit)
Table 40. Global Fibroblast Growth Factors (FGF) Sales by Application (2017-2022) & (K Units)
Table 41. Global Fibroblast Growth Factors (FGF) Sales by Application (2023-2028) & (K Units)
Table 42. Global Fibroblast Growth Factors (FGF) Sales Share by Application (2017-2022)
Table 43. Global Fibroblast Growth Factors (FGF) Sales Share by Application (2023-2028)
Table 44. Global Fibroblast Growth Factors (FGF) Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Fibroblast Growth Factors (FGF) Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Fibroblast Growth Factors (FGF) Revenue Share by Application (2017-2022)
Table 47. Global Fibroblast Growth Factors (FGF) Revenue Share by Application (2023-2028)
Table 48. Fibroblast Growth Factors (FGF) Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Fibroblast Growth Factors (FGF) Price Forecast by Application (2023-2028) & (US$/Unit)
Table 50. North America Fibroblast Growth Factors (FGF) Sales by Type (2017-2022) & (K Units)
Table 51. North America Fibroblast Growth Factors (FGF) Sales by Type (2023-2028) & (K Units)
Table 52. North America Fibroblast Growth Factors (FGF) Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Fibroblast Growth Factors (FGF) Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Fibroblast Growth Factors (FGF) Sales by Application (2017-2022) & (K Units)
Table 55. North America Fibroblast Growth Factors (FGF) Sales by Application (2023-2028) & (K Units)
Table 56. North America Fibroblast Growth Factors (FGF) Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Fibroblast Growth Factors (FGF) Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Fibroblast Growth Factors (FGF) Sales by Country (2017-2022) & (K Units)
Table 59. North America Fibroblast Growth Factors (FGF) Sales by Country (2023-2028) & (K Units)
Table 60. North America Fibroblast Growth Factors (FGF) Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Fibroblast Growth Factors (FGF) Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Fibroblast Growth Factors (FGF) Sales by Type (2017-2022) & (K Units)
Table 63. Europe Fibroblast Growth Factors (FGF) Sales by Type (2023-2028) & (K Units)
Table 64. Europe Fibroblast Growth Factors (FGF) Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Fibroblast Growth Factors (FGF) Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Fibroblast Growth Factors (FGF) Sales by Application (2017-2022) & (K Units)
Table 67. Europe Fibroblast Growth Factors (FGF) Sales by Application (2023-2028) & (K Units)
Table 68. Europe Fibroblast Growth Factors (FGF) Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Fibroblast Growth Factors (FGF) Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Fibroblast Growth Factors (FGF) Sales by Country (2017-2022) & (K Units)
Table 71. Europe Fibroblast Growth Factors (FGF) Sales by Country (2023-2028) & (K Units)
Table 72. Europe Fibroblast Growth Factors (FGF) Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Fibroblast Growth Factors (FGF) Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Fibroblast Growth Factors (FGF) Sales by Type (2017-2022) & (K Units)
Table 75. Asia Pacific Fibroblast Growth Factors (FGF) Sales by Type (2023-2028) & (K Units)
Table 76. Asia Pacific Fibroblast Growth Factors (FGF) Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Fibroblast Growth Factors (FGF) Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Fibroblast Growth Factors (FGF) Sales by Application (2017-2022) & (K Units)
Table 79. Asia Pacific Fibroblast Growth Factors (FGF) Sales by Application (2023-2028) & (K Units)
Table 80. Asia Pacific Fibroblast Growth Factors (FGF) Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Fibroblast Growth Factors (FGF) Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Fibroblast Growth Factors (FGF) Sales by Region (2017-2022) & (K Units)
Table 83. Asia Pacific Fibroblast Growth Factors (FGF) Sales by Region (2023-2028) & (K Units)
Table 84. Asia Pacific Fibroblast Growth Factors (FGF) Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Fibroblast Growth Factors (FGF) Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Fibroblast Growth Factors (FGF) Sales by Type (2017-2022) & (K Units)
Table 87. Latin America Fibroblast Growth Factors (FGF) Sales by Type (2023-2028) & (K Units)
Table 88. Latin America Fibroblast Growth Factors (FGF) Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Fibroblast Growth Factors (FGF) Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Fibroblast Growth Factors (FGF) Sales by Application (2017-2022) & (K Units)
Table 91. Latin America Fibroblast Growth Factors (FGF) Sales by Application (2023-2028) & (K Units)
Table 92. Latin America Fibroblast Growth Factors (FGF) Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Fibroblast Growth Factors (FGF) Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Fibroblast Growth Factors (FGF) Sales by Country (2017-2022) & (K Units)
Table 95. Latin America Fibroblast Growth Factors (FGF) Sales by Country (2023-2028) & (K Units)
Table 96. Latin America Fibroblast Growth Factors (FGF) Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Fibroblast Growth Factors (FGF) Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Fibroblast Growth Factors (FGF) Sales by Type (2017-2022) & (K Units)
Table 99. Middle East and Africa Fibroblast Growth Factors (FGF) Sales by Type (2023-2028) & (K Units)
Table 100. Middle East and Africa Fibroblast Growth Factors (FGF) Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Fibroblast Growth Factors (FGF) Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Fibroblast Growth Factors (FGF) Sales by Application (2017-2022) & (K Units)
Table 103. Middle East and Africa Fibroblast Growth Factors (FGF) Sales by Application (2023-2028) & (K Units)
Table 104. Middle East and Africa Fibroblast Growth Factors (FGF) Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Fibroblast Growth Factors (FGF) Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Fibroblast Growth Factors (FGF) Sales by Country (2017-2022) & (K Units)
Table 107. Middle East and Africa Fibroblast Growth Factors (FGF) Sales by Country (2023-2028) & (K Units)
Table 108. Middle East and Africa Fibroblast Growth Factors (FGF) Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Fibroblast Growth Factors (FGF) Revenue by Country (2023-2028) & (US$ Million)
Table 110. ProSpec Corporation Information
Table 111. ProSpec Description and Major Businesses
Table 112. ProSpec Fibroblast Growth Factors (FGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. ProSpec Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. ProSpec Recent Developments
Table 115. Thermo Fisher Scientific Corporation Information
Table 116. Thermo Fisher Scientific Description and Major Businesses
Table 117. Thermo Fisher Scientific Fibroblast Growth Factors (FGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Thermo Fisher Scientific Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Thermo Fisher Scientific Recent Developments
Table 120. Peprotech Corporation Information
Table 121. Peprotech Description and Major Businesses
Table 122. Peprotech Fibroblast Growth Factors (FGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Peprotech Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Peprotech Recent Developments
Table 125. Essex Bio-Technology Corporation Information
Table 126. Essex Bio-Technology Description and Major Businesses
Table 127. Essex Bio-Technology Fibroblast Growth Factors (FGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Essex Bio-Technology Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Essex Bio-Technology Recent Developments
Table 130. Corning Corporation Information
Table 131. Corning Description and Major Businesses
Table 132. Corning Fibroblast Growth Factors (FGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Corning Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Corning Recent Developments
Table 135. Lonza Corporation Information
Table 136. Lonza Description and Major Businesses
Table 137. Lonza Fibroblast Growth Factors (FGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Lonza Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Lonza Recent Developments
Table 140. Shanghai Tenry Pharmaceutical Corporation Information
Table 141. Shanghai Tenry Pharmaceutical Description and Major Businesses
Table 142. Shanghai Tenry Pharmaceutical Fibroblast Growth Factors (FGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Shanghai Tenry Pharmaceutical Fibroblast Growth Factors (FGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Shanghai Tenry Pharmaceutical Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Fibroblast Growth Factors (FGF) Distributors List
Table 148. Fibroblast Growth Factors (FGF) Customers List
Table 149. Fibroblast Growth Factors (FGF) Market Trends
Table 150. Fibroblast Growth Factors (FGF) Market Drivers
Table 151. Fibroblast Growth Factors (FGF) Market Challenges
Table 152. Fibroblast Growth Factors (FGF) Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Fibroblast Growth Factors (FGF) Product Picture
Figure 3. Global Fibroblast Growth Factors (FGF) Market Share by Type in 2021 & 2028
Figure 3. FGF1 Product Picture
Figure 4. FGF4 Product Picture
Figure 5. FGF7 Product Picture
Figure 6. FGF8 Product Picture
Figure 7. FGF9 Product Picture
Figure 8. FGF11 Product Picture
Figure 9. FGF19 Product Picture
Figure 10. Global Fibroblast Growth Factors (FGF) Market Share by Application in 2021 & 2028
Figure 11. Cardiovascular Diseases
Figure 12. Skin Disease
Figure 13. Cancer
Figure 14. Other
Figure 15. Fibroblast Growth Factors (FGF) Report Years Considered
Figure 16. Global Fibroblast Growth Factors (FGF) Sales 2017-2028 (K Units)
Figure 17. Global Fibroblast Growth Factors (FGF) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Fibroblast Growth Factors (FGF) Revenue 2017-2028 (US$ Million)
Figure 19. Global Fibroblast Growth Factors (FGF) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Fibroblast Growth Factors (FGF) Sales Market Share by Region (2017-2022)
Figure 21. Global Fibroblast Growth Factors (FGF) Sales Market Share by Region (2023-2028)
Figure 22. North America Fibroblast Growth Factors (FGF) Sales YoY (2017-2028) & (K Units)
Figure 23. North America Fibroblast Growth Factors (FGF) Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Fibroblast Growth Factors (FGF) Sales YoY (2017-2028) & (K Units)
Figure 25. Europe Fibroblast Growth Factors (FGF) Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Fibroblast Growth Factors (FGF) Sales YoY (2017-2028) & (K Units)
Figure 27. Asia-Pacific Fibroblast Growth Factors (FGF) Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Fibroblast Growth Factors (FGF) Sales YoY (2017-2028) & (K Units)
Figure 29. Latin America Fibroblast Growth Factors (FGF) Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Fibroblast Growth Factors (FGF) Sales YoY (2017-2028) & (K Units)
Figure 31. Middle East & Africa Fibroblast Growth Factors (FGF) Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Fibroblast Growth Factors (FGF) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Fibroblast Growth Factors (FGF) in the World: Market Share by Fibroblast Growth Factors (FGF) Revenue in 2021
Figure 34. Global Fibroblast Growth Factors (FGF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Fibroblast Growth Factors (FGF) Sales Market Share by Type (2017-2028)
Figure 36. Global Fibroblast Growth Factors (FGF) Revenue Market Share by Type (2017-2028)
Figure 37. Global Fibroblast Growth Factors (FGF) Sales Market Share by Application (2017-2028)
Figure 38. Global Fibroblast Growth Factors (FGF) Revenue Market Share by Application (2017-2028)
Figure 39. North America Fibroblast Growth Factors (FGF) Sales Market Share by Type (2017-2028)
Figure 40. North America Fibroblast Growth Factors (FGF) Revenue Market Share by Type (2017-2028)
Figure 41. North America Fibroblast Growth Factors (FGF) Sales Market Share by Application (2017-2028)
Figure 42. North America Fibroblast Growth Factors (FGF) Revenue Market Share by Application (2017-2028)
Figure 43. North America Fibroblast Growth Factors (FGF) Sales Share by Country (2017-2028)
Figure 44. North America Fibroblast Growth Factors (FGF) Revenue Share by Country (2017-2028)
Figure 45. United States Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Fibroblast Growth Factors (FGF) Sales Market Share by Type (2017-2028)
Figure 48. Europe Fibroblast Growth Factors (FGF) Revenue Market Share by Type (2017-2028)
Figure 49. Europe Fibroblast Growth Factors (FGF) Sales Market Share by Application (2017-2028)
Figure 50. Europe Fibroblast Growth Factors (FGF) Revenue Market Share by Application (2017-2028)
Figure 51. Europe Fibroblast Growth Factors (FGF) Sales Share by Country (2017-2028)
Figure 52. Europe Fibroblast Growth Factors (FGF) Revenue Share by Country (2017-2028)
Figure 53. Germany Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 54. France Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Fibroblast Growth Factors (FGF) Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Fibroblast Growth Factors (FGF) Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Fibroblast Growth Factors (FGF) Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Fibroblast Growth Factors (FGF) Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Fibroblast Growth Factors (FGF) Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Fibroblast Growth Factors (FGF) Revenue Share by Region (2017-2028)
Figure 64. China Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 67. India Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 69. China Taiwan Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Fibroblast Growth Factors (FGF) Sales Market Share by Type (2017-2028)
Figure 74. Latin America Fibroblast Growth Factors (FGF) Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Fibroblast Growth Factors (FGF) Sales Market Share by Application (2017-2028)
Figure 76. Latin America Fibroblast Growth Factors (FGF) Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Fibroblast Growth Factors (FGF) Sales Share by Country (2017-2028)
Figure 78. Latin America Fibroblast Growth Factors (FGF) Revenue Share by Country (2017-2028)
Figure 79. Mexico Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 82. Colombia Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Fibroblast Growth Factors (FGF) Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Fibroblast Growth Factors (FGF) Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Fibroblast Growth Factors (FGF) Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Fibroblast Growth Factors (FGF) Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Fibroblast Growth Factors (FGF) Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Fibroblast Growth Factors (FGF) Revenue Share by Country (2017-2028)
Figure 89. Turkey Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Fibroblast Growth Factors (FGF) Revenue (2017-2028) & (US$ Million)
Figure 92. Fibroblast Growth Factors (FGF) Value Chain
Figure 93. Fibroblast Growth Factors (FGF) Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

---